Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neuralstem Inc (NASDAQ:CUR)

1.42
Delayed Data
As of Oct 20
 +0.08 / +5.97%
Today’s Change
0.99
Today|||52-Week Range
6.60
-60.05%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$17.2M

Company Description

Neuralstem, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel and proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.

Contact Information

Neuralstem, Inc.
20271 Goldenrod Lane
Germantown Maryland 20876
P:(301) 366-4960
Investor Relations:
(301) 366-1481

Employees

Shareholders

Mutual fund holders4.55%
Individual stakeholders2.09%
Other institutional13.85%

Top Executives

Richard J. DalyChairman, President, Chief Executive Officer & CFO
Karl Y. JoheChief Scientific Officer
Thomas HazelSenior Vice President-Research
Danielle SpanglerDirector-Investor Relations